197 related articles for article (PubMed ID: 33548010)
1. Rho-kinase inhibitor hydroxyfasudil protects against HIV-1 Tat-induced dysfunction of tight junction and neprilysin/Aβ transfer receptor expression in mouse brain microvessels.
Chen Q; Wu Y; Yu Y; Wei J; Huang W
Mol Cell Biochem; 2021 May; 476(5):2159-2170. PubMed ID: 33548010
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Tat Regulates Occludin and Aβ Transfer Receptor Expression in Brain Endothelial Cells via Rho/ROCK Signaling Pathway.
Chen Y; Huang W; Jiang W; Wu X; Ye B; Zhou X
Oxid Med Cell Longev; 2016; 2016():4196572. PubMed ID: 27563375
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Transactivator Protein Induces ZO-1 and Neprilysin Dysfunction in Brain Endothelial Cells via the Ras Signaling Pathway.
Jiang W; Huang W; Chen Y; Zou M; Peng D; Chen D
Oxid Med Cell Longev; 2017; 2017():3160360. PubMed ID: 28553432
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rho kinase by hydroxyfasudil attenuates brain edema after subarachnoid hemorrhage in rats.
Fujii M; Duris K; Altay O; Soejima Y; Sherchan P; Zhang JH
Neurochem Int; 2012 Feb; 60(3):327-33. PubMed ID: 22226843
[TBL] [Abstract][Full Text] [Related]
5. Role of Cav-1 in HIV-1 Tat-Induced Dysfunction of Tight Junctions and A
Zou M; Huang W; Jiang W; Wu Y; Chen Q
Oxid Med Cell Longev; 2019; 2019():3403206. PubMed ID: 31217837
[TBL] [Abstract][Full Text] [Related]
6. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
7. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability.
Feng S; Zou L; Wang H; He R; Liu K; Zhu H
Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623
[TBL] [Abstract][Full Text] [Related]
8. HIV Tat-mediated induction of autophagy regulates the disruption of ZO-1 in brain endothelial cells.
Liao K; Niu F; Hu G; Guo ML; Sil S; Buch S
Tissue Barriers; 2020 Apr; 8(2):1748983. PubMed ID: 32299282
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation.
Zhong Y; Zhang B; Eum SY; Toborek M
J Neurosci; 2012 Jan; 32(1):143-50. PubMed ID: 22219277
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9.
Xu R; Feng X; Xie X; Zhang J; Wu D; Xu L
Brain Res; 2012 Feb; 1436():13-9. PubMed ID: 22197032
[TBL] [Abstract][Full Text] [Related]
11. Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis.
Lai PH; Wang TH; Zhang NY; Wu KC; Yao CJ; Lin CJ
J Neuroinflammation; 2021 Jan; 18(1):35. PubMed ID: 33516259
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M
J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355
[TBL] [Abstract][Full Text] [Related]
13. Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood-brain barrier.
Pu H; Hayashi K; Andras IE; Eum SY; Hennig B; Toborek M
Brain Res; 2007 Dec; 1184():333-44. PubMed ID: 17976544
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Tat inhibits neprilysin and elevates amyloid beta.
Rempel HC; Pulliam L
AIDS; 2005 Jan; 19(2):127-35. PubMed ID: 15668537
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat protein alter the tight junction integrity and function of retinal pigment epithelium: an in vitro study.
Bai L; Zhang Z; Zhang H; Li X; Yu Q; Lin H; Yang W
BMC Infect Dis; 2008 Jun; 8():77. PubMed ID: 18538010
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U
J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233
[TBL] [Abstract][Full Text] [Related]
17. CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.
Bhargavan B; Woollard SM; McMillan JE; Kanmogne GD
Mol Neurodegener; 2021 Nov; 16(1):78. PubMed ID: 34809709
[TBL] [Abstract][Full Text] [Related]
18. Oligomeric Tau-induced oxidative damage and functional alterations in cerebral endothelial cells: Role of RhoA/ROCK signaling pathway.
Hossen F; Sun GY; Lee JC
Free Radic Biol Med; 2024 Aug; 221():261-272. PubMed ID: 38815773
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling.
Zhong Y; Smart EJ; Weksler B; Couraud PO; Hennig B; Toborek M
J Neurosci; 2008 Jul; 28(31):7788-96. PubMed ID: 18667611
[TBL] [Abstract][Full Text] [Related]
20. Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins.
Wan W; Cao L; Liu L; Zhang C; Kalionis B; Tai X; Li Y; Xia S
J Neurochem; 2015 Jul; 134(2):382-93. PubMed ID: 25866188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]